Contact Us

Diabetes

DiagnoSearch has supported diabetes clinical trials for three decades, across both Type I and Type II diabetes. Our experience covers global development of a broad spectrum of investigational products - including DPP-4 inhibitors, insulin and insulin analogs, monoclonal antibodies, SGLT-2 inhibitors, thiazolidinedione, combination therapies, and innovative medical devices.

Breadth of Diabetes Clinical Trial Expertise

With 40+ diabetes clinical trials conducted across Phases I–IV, our teams bring therapeutic insight and operational strength to studies of varying scale. We have supported both early-phase development and large late-phase programs, including real-world evidence generation.

Highlights from Our Diabetes Clinical Trials

40+ studies across Phases I–IV
A large multi-year registry involving 450 sites and 5,600 participants
Demonstrated strength in high-volume recruitment and complex protocol execution

A Trusted Partner in Diabetes Clinical Trial Development Research

We recognize the nuances of diabetes studies, from patient adherence to endpoint clarity and approach each program with precision and care. With three decades of diabetes clinical research behind us, DiagnoSearch offers sponsors the confidence of reliable execution and meaningful results.